Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2025-12-25 @ 2:02 AM
NCT ID:
NCT04508660
Brief Summary:
Open-label multicenter study using CGB-400 Gel (cosmetic) to reduce facial redness
Detailed Description:
This is a Open-label multicenter study to evaluate the ability of CGB-400 Gel to reduce facial redness typically associated with rosacea. Approximately 25 subjects will be enrolled.
Subjects will receive study treatment for 4 weeks and attend a total of 4 study visits (BL, W1, W2, W4).
Study:
NCT04508660
Study Brief:
Protocol Section:
NCT04508660